Guo J - Search Results

1

A novel subtype of primary prostatic adenocarcinoma: A case report.

Yang X, Xu C, Guo J, Yang C, Yang Y, Han R. Yang X, et al. Among authors: guo j. Oncol Lett. 2013 Nov;6(5):1303-1306. doi: 10.3892/ol.2013.1557. Epub 2013 Sep 2. Oncol Lett. 2013. PMID: 24179513 Free PMC article.

2

Pim-3 is a Critical Risk Factor in Development and Prognosis of Prostate Cancer.

Qu Y, Zhang C, Du E, Wang A, Yang Y, Guo J, Wang A, Zhang Z, Xu Y. Qu Y, et al. Among authors: guo j. Med Sci Monit. 2016 Nov 9;22:4254-4260. doi: 10.12659/msm.898223. Med Sci Monit. 2016. PMID: 27826135 Free PMC article.

3

[Clinicopathological features of primary seminal vesicle adenocarcinoma: A report of 4 cases and review of the literature].

Guo JN, Li H, Hu ZD, Liang EL, Chang JW. Guo JN, et al. Zhonghua Nan Ke Xue. 2017 Jul;23(7):639-645. Zhonghua Nan Ke Xue. 2017. PMID: 29723459 Review. Chinese.

4

Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results.

Ma B, Li Y, Han S, Jiang X, Zhao Y, Guo J, Quan C, Niu Y. Ma B, et al. Among authors: guo j. Eur J Surg Oncol. 2019 Oct;45(10):1993-1999. doi: 10.1016/j.ejso.2019.07.018. Epub 2019 Jul 16. Eur J Surg Oncol. 2019. PMID: 31327502

5

[Analysis of Clinicopathological Characteristics and Factors Affecting the Prognosis of Patients With Resectable Sarcomatoid Carcinoma of the Bladder].

Huang S, Jia K, Shen C, Chen H, Zhang Z, Wu Z, Qie Y, Guo J, Hu H. Huang S, et al. Among authors: guo j. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Sep 20;55(5):1085-1091. doi: 10.12182/20240960102. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39507980 Free PMC article. Chinese.

6

BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway.

Jiang N, Liao Y, Wang M, Wang Y, Wang K, Guo J, Wu P, Zhong B, Guo T, Wu C. Jiang N, et al. Among authors: guo t, guo j. J Exp Clin Cancer Res. 2021 Dec 1;40(1):378. doi: 10.1186/s13046-021-02179-z. J Exp Clin Cancer Res. 2021. PMID: 34852826 Free PMC article.

7

Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic study.

Wang Y, Wu N, Wang K, Liao Y, Guo J, Zhong B, Guo T, Liang J, Jiang N. Wang Y, et al. Among authors: guo t, guo j. Front Genet. 2022 Sep 2;13:955133. doi: 10.3389/fgene.2022.955133. eCollection 2022. Front Genet. 2022. PMID: 36118857 Free PMC article.

8

HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer.

Zhu S, Yang Z, Zhang Z, Zhang H, Li S, Wu T, Chen X, Guo J, Wang A, Tian H, Yu J, Zhang C, Su L, Shang Z, Quan C, Niu Y. Zhu S, et al. Among authors: guo j. Cell Death Dis. 2023 Mar 27;14(3):215. doi: 10.1038/s41419-023-05742-y. Cell Death Dis. 2023. PMID: 36973255 Free PMC article.

9

Target deubiquitinase OTUB1 as a therapeatic strategy for BLCA via β-catenin/necroptosis signal pathway.

Liao Y, Liang J, Wang Y, Li A, Liu W, Zhong B, Wang K, Zhou D, Guo T, Guo J, Yu X, Jiang N. Liao Y, et al. Among authors: guo t, guo j. Int J Biol Sci. 2024 Jul 2;20(10):3784-3801. doi: 10.7150/ijbs.94013. eCollection 2024. Int J Biol Sci. 2024. PMID: 39113709 Free PMC article.

10

TNIK drives castration-resistant prostate cancer via phosphorylating EGFR.

Guo J, Liang J, Wang Y, Guo T, Liao Y, Zhong B, Guo S, Cao Q, Li J, Flores-Morales A, Niu Y, Jiang N. Guo J, et al. Among authors: guo s, guo t. iScience. 2023 Dec 12;27(1):108713. doi: 10.1016/j.isci.2023.108713. eCollection 2024 Jan 19. iScience. 2023. PMID: 38226156 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,764 results

Search Page

Filters